Global Active Pharmaceutical Ingredients (API) Market Insights and Forecast to 2031

Report ID: 1123296 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Active Pharmaceutical Ingredients (API) Product Introduction
    1.2 Market by Type
        1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Synthetic APIs
        1.2.3 Biotech APIs
    1.3 Market by Application
        1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 CNS
        1.3.3 Cardiovascular
        1.3.4 Genitourinary/Hormonal Drugs
        1.3.5 Respiratory
        1.3.6 Rheumatology
        1.3.7 Diabetes
        1.3.8 Oncology
        1.3.9 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Active Pharmaceutical Ingredients (API) Production
    2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity (2017-2028)
    2.2 Global Active Pharmaceutical Ingredients (API) Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Active Pharmaceutical Ingredients (API) Production by Region
        2.3.1 Global Active Pharmaceutical Ingredients (API) Historic Production by Region (2017-2022)
        2.3.2 Global Active Pharmaceutical Ingredients (API) Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
    2.8 India
3 Global Active Pharmaceutical Ingredients (API) Sales in Volume & Value Estimates and Forecasts
    3.1 Global Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts 2017-2028
    3.2 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts 2017-2028
    3.3 Global Active Pharmaceutical Ingredients (API) Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Active Pharmaceutical Ingredients (API) Sales by Region
        3.4.1 Global Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022)
        3.4.2 Global Sales Active Pharmaceutical Ingredients (API) by Region (2023-2028)
    3.5 Global Active Pharmaceutical Ingredients (API) Revenue by Region
        3.5.1 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022)
        3.5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Active Pharmaceutical Ingredients (API) Production Capacity by Manufacturers
    4.2 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers
        4.2.1 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2017-2022)
        4.2.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Active Pharmaceutical Ingredients (API) in 2021
    4.3 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
        4.3.1 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2017-2022)
        4.3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2021
    4.4 Global Active Pharmaceutical Ingredients (API) Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Active Pharmaceutical Ingredients (API) Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Active Pharmaceutical Ingredients (API) Sales by Type
        5.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Type (2017-2022)
        5.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Type (2023-2028)
        5.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type
        5.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Type (2017-2022)
        5.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    5.3 Global Active Pharmaceutical Ingredients (API) Price by Type
        5.3.1 Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2022)
        5.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Active Pharmaceutical Ingredients (API) Sales by Application
        6.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Application (2017-2022)
        6.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Application (2023-2028)
        6.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application
        6.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Application (2017-2022)
        6.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    6.3 Global Active Pharmaceutical Ingredients (API) Price by Application
        6.3.1 Global Active Pharmaceutical Ingredients (API) Price by Application (2017-2022)
        6.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Active Pharmaceutical Ingredients (API) Market Size by Type
        7.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)
        7.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)
    7.2 North America Active Pharmaceutical Ingredients (API) Market Size by Application
        7.2.1 North America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)
        7.2.2 North America Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)
    7.3 North America Active Pharmaceutical Ingredients (API) Sales by Country
        7.3.1 North America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2028)
        7.3.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Active Pharmaceutical Ingredients (API) Market Size by Type
        8.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)
        8.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)
    8.2 Europe Active Pharmaceutical Ingredients (API) Market Size by Application
        8.2.1 Europe Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)
        8.2.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)
    8.3 Europe Active Pharmaceutical Ingredients (API) Sales by Country
        8.3.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country (2017-2028)
        8.3.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size by Type
        9.1.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)
        9.1.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)
    9.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size by Application
        9.2.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)
        9.2.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)
    9.3 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region
        9.3.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2017-2028)
        9.3.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Active Pharmaceutical Ingredients (API) Market Size by Type
        10.1.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)
        10.1.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)
    10.2 Latin America Active Pharmaceutical Ingredients (API) Market Size by Application
        10.2.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)
        10.2.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)
    10.3 Latin America Active Pharmaceutical Ingredients (API) Sales by Country
        10.3.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2028)
        10.3.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size by Type
        11.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)
    11.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size by Application
        11.2.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)
    11.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country
        11.3.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 U.A.E
12 Corporate Profiles
    12.1 Teva
        12.1.1 Teva Corporation Information
        12.1.2 Teva Overview
        12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Teva Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Teva Recent Developments
    12.2 Mylan
        12.2.1 Mylan Corporation Information
        12.2.2 Mylan Overview
        12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Mylan Recent Developments
    12.3 DSM
        12.3.1 DSM Corporation Information
        12.3.2 DSM Overview
        12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 DSM Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 DSM Recent Developments
    12.4 Aurobindo Pharma
        12.4.1 Aurobindo Pharma Corporation Information
        12.4.2 Aurobindo Pharma Overview
        12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Aurobindo Pharma Recent Developments
    12.5 Aspen
        12.5.1 Aspen Corporation Information
        12.5.2 Aspen Overview
        12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Aspen Recent Developments
    12.6 Novartis
        12.6.1 Novartis Corporation Information
        12.6.2 Novartis Overview
        12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Novartis Recent Developments
    12.7 BASF
        12.7.1 BASF Corporation Information
        12.7.2 BASF Overview
        12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 BASF Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 BASF Recent Developments
    12.8 Pfizer
        12.8.1 Pfizer Corporation Information
        12.8.2 Pfizer Overview
        12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Pfizer Recent Developments
    12.9 Huahai Pharmaceutical
        12.9.1 Huahai Pharmaceutical Corporation Information
        12.9.2 Huahai Pharmaceutical Overview
        12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Huahai Pharmaceutical Recent Developments
    12.10 Hisun Pharmaceutical
        12.10.1 Hisun Pharmaceutical Corporation Information
        12.10.2 Hisun Pharmaceutical Overview
        12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.10.5 Hisun Pharmaceutical Recent Developments
    12.11 Sun Pharmaceutical Industries
        12.11.1 Sun Pharmaceutical Industries Corporation Information
        12.11.2 Sun Pharmaceutical Industries Overview
        12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.11.5 Sun Pharmaceutical Industries Recent Developments
    12.12 Zhejiang Medicine
        12.12.1 Zhejiang Medicine Corporation Information
        12.12.2 Zhejiang Medicine Overview
        12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.12.5 Zhejiang Medicine Recent Developments
    12.13 Dr. Reddy’s Laboratories
        12.13.1 Dr. Reddy’s Laboratories Corporation Information
        12.13.2 Dr. Reddy’s Laboratories Overview
        12.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.13.5 Dr. Reddy’s Laboratories Recent Developments
    12.14 Zhejiang NHU
        12.14.1 Zhejiang NHU Corporation Information
        12.14.2 Zhejiang NHU Overview
        12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.14.5 Zhejiang NHU Recent Developments
    12.15 Bayer
        12.15.1 Bayer Corporation Information
        12.15.2 Bayer Overview
        12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.15.5 Bayer Recent Developments
    12.16 NCPC
        12.16.1 NCPC Corporation Information
        12.16.2 NCPC Overview
        12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.16.5 NCPC Recent Developments
    12.17 AbbVie
        12.17.1 AbbVie Corporation Information
        12.17.2 AbbVie Overview
        12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.17.5 AbbVie Recent Developments
    12.18 Shandong Xinhua Pharmaceutical
        12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
        12.18.2 Shandong Xinhua Pharmaceutical Overview
        12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.18.5 Shandong Xinhua Pharmaceutical Recent Developments
    12.19 Northeast Pharm
        12.19.1 Northeast Pharm Corporation Information
        12.19.2 Northeast Pharm Overview
        12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.19.5 Northeast Pharm Recent Developments
    12.20 Harbin Pharmaceutical
        12.20.1 Harbin Pharmaceutical Corporation Information
        12.20.2 Harbin Pharmaceutical Overview
        12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.20.5 Harbin Pharmaceutical Recent Developments
    12.21 LKPC
        12.21.1 LKPC Corporation Information
        12.21.2 LKPC Overview
        12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
        12.21.5 LKPC Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Active Pharmaceutical Ingredients (API) Industry Chain Analysis
    13.2 Active Pharmaceutical Ingredients (API) Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Active Pharmaceutical Ingredients (API) Production Mode & Process
    13.4 Active Pharmaceutical Ingredients (API) Sales and Marketing
        13.4.1 Active Pharmaceutical Ingredients (API) Sales Channels
        13.4.2 Active Pharmaceutical Ingredients (API) Distributors
    13.5 Active Pharmaceutical Ingredients (API) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Active Pharmaceutical Ingredients (API) Industry Trends
    14.2 Active Pharmaceutical Ingredients (API) Market Drivers
    14.3 Active Pharmaceutical Ingredients (API) Market Challenges
    14.4 Active Pharmaceutical Ingredients (API) Market Restraints
15 Key Finding in The Global Active Pharmaceutical Ingredients (API) Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Synthetic APIs
    Table 3. Major Manufacturers of Biotech APIs
    Table 4. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global Active Pharmaceutical Ingredients (API) Production by Region: 2017 VS 2021 VS 2028 (Tons)
    Table 6. Global Active Pharmaceutical Ingredients (API) Production by Region (2017-2022) & (Tons)
    Table 7. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2017-2022)
    Table 8. Global Active Pharmaceutical Ingredients (API) Production by Region (2023-2028) & (Tons)
    Table 9. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2023-2028)
    Table 10. Global Active Pharmaceutical Ingredients (API) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (Tons)
    Table 12. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2022)
    Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (Tons)
    Table 14. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2023-2028)
    Table 15. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2022)
    Table 17. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2023-2028)
    Table 19. Global Active Pharmaceutical Ingredients (API) Production Capacity by Manufacturers (2017-2022) & (Tons)
    Table 20. Global Active Pharmaceutical Ingredients (API) Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2017-2022) & (Tons)
    Table 22. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2017-2022)
    Table 25. Active Pharmaceutical Ingredients (API) Price by Manufacturers 2017-2022 (USD/Ton)
    Table 26. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2021)
    Table 28. Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Active Pharmaceutical Ingredients (API) Product Offered
    Table 30. Date of Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 33. Global Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 34. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2017-2022)
    Table 35. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2023-2028)
    Table 36. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2017-2022)
    Table 39. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2023-2028)
    Table 40. Active Pharmaceutical Ingredients (API) Price by Type (2017-2022) & (USD/Ton)
    Table 41. Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2023-2028) & (USD/Ton)
    Table 42. Global Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 43. Global Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 44. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2017-2022)
    Table 45. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2023-2028)
    Table 46. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2017-2022)
    Table 49. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2023-2028)
    Table 50. Active Pharmaceutical Ingredients (API) Price by Application (2017-2022) & (USD/Ton)
    Table 51. Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2023-2028) & (USD/Ton)
    Table 52. North America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 53. North America Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 54. North America Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 57. North America Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 58. North America Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)
    Table 61. North America Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)
    Table 62. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 65. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 66. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 69. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 70. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)
    Table 73. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)
    Table 74. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 77. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 78. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 81. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 82. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (Tons)
    Table 85. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (Tons)
    Table 86. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 89. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 90. Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 93. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 94. Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)
    Table 97. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)
    Table 98. Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)
    Table 101. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)
    Table 102. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)
    Table 105. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)
    Table 106. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)
    Table 109. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)
    Table 110. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Teva Corporation Information
    Table 113. Teva Description and Major Businesses
    Table 114. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 115. Teva Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Teva Recent Development
    Table 117. Mylan Corporation Information
    Table 118. Mylan Description and Major Businesses
    Table 119. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 120. Mylan Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Mylan Recent Development
    Table 122. DSM Corporation Information
    Table 123. DSM Description and Major Businesses
    Table 124. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 125. DSM Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. DSM Recent Development
    Table 127. Aurobindo Pharma Corporation Information
    Table 128. Aurobindo Pharma Description and Major Businesses
    Table 129. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 130. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Aurobindo Pharma Recent Development
    Table 132. Aspen Corporation Information
    Table 133. Aspen Description and Major Businesses
    Table 134. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 135. Aspen Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Aspen Recent Development
    Table 137. Novartis Corporation Information
    Table 138. Novartis Description and Major Businesses
    Table 139. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 140. Novartis Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Novartis Recent Development
    Table 142. BASF Corporation Information
    Table 143. BASF Description and Major Businesses
    Table 144. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 145. BASF Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. BASF Recent Development
    Table 147. Pfizer Corporation Information
    Table 148. Pfizer Description and Major Businesses
    Table 149. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 150. Pfizer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Pfizer Recent Development
    Table 152. Huahai Pharmaceutical Corporation Information
    Table 153. Huahai Pharmaceutical Description and Major Businesses
    Table 154. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 155. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Huahai Pharmaceutical Recent Development
    Table 157. Hisun Pharmaceutical Corporation Information
    Table 158. Hisun Pharmaceutical Description and Major Businesses
    Table 159. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 160. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hisun Pharmaceutical Recent Development
    Table 162. Sun Pharmaceutical Industries Corporation Information
    Table 163. Sun Pharmaceutical Industries Description and Major Businesses
    Table 164. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 165. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Sun Pharmaceutical Industries Recent Development
    Table 167. Zhejiang Medicine Corporation Information
    Table 168. Zhejiang Medicine Description and Major Businesses
    Table 169. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 170. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Zhejiang Medicine Recent Development
    Table 172. Dr. Reddy’s Laboratories Corporation Information
    Table 173. Dr. Reddy’s Laboratories Description and Major Businesses
    Table 174. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 175. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Dr. Reddy’s Laboratories Recent Development
    Table 177. Zhejiang NHU Corporation Information
    Table 178. Zhejiang NHU Description and Major Businesses
    Table 179. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 180. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Zhejiang NHU Recent Development
    Table 182. Bayer Corporation Information
    Table 183. Bayer Description and Major Businesses
    Table 184. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 185. Bayer Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Bayer Recent Development
    Table 187. NCPC Corporation Information
    Table 188. NCPC Description and Major Businesses
    Table 189. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 190. NCPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. NCPC Recent Development
    Table 192. AbbVie Corporation Information
    Table 193. AbbVie Description and Major Businesses
    Table 194. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 195. AbbVie Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 196. AbbVie Recent Development
    Table 197. Shandong Xinhua Pharmaceutical Corporation Information
    Table 198. Shandong Xinhua Pharmaceutical Description and Major Businesses
    Table 199. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 200. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 201. Shandong Xinhua Pharmaceutical Recent Development
    Table 202. Northeast Pharm Corporation Information
    Table 203. Northeast Pharm Description and Major Businesses
    Table 204. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 205. Northeast Pharm Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 206. Northeast Pharm Recent Development
    Table 207. Harbin Pharmaceutical Corporation Information
    Table 208. Harbin Pharmaceutical Description and Major Businesses
    Table 209. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 210. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 211. Harbin Pharmaceutical Recent Development
    Table 212. LKPC Corporation Information
    Table 213. LKPC Description and Major Businesses
    Table 214. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 215. LKPC Active Pharmaceutical Ingredients (API) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 216. LKPC Recent Development
    Table 217. Key Raw Materials Lists
    Table 218. Raw Materials Key Suppliers Lists
    Table 219. Active Pharmaceutical Ingredients (API) Distributors List
    Table 220. Active Pharmaceutical Ingredients (API) Customers List
    Table 221. Active Pharmaceutical Ingredients (API) Market Trends
    Table 222. Active Pharmaceutical Ingredients (API) Market Drivers
    Table 223. Active Pharmaceutical Ingredients (API) Market Challenges
    Table 224. Active Pharmaceutical Ingredients (API) Market Restraints
    Table 225. Research Programs/Design for This Report
    Table 226. Key Data Information from Secondary Sources
    Table 227. Key Data Information from Primary Sources
List of Figures
    Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
    Figure 2. Global Active Pharmaceutical Ingredients (API) Market Share by Type in 2021 & 2028
    Figure 3. Synthetic APIs Product Picture
    Figure 4. Biotech APIs Product Picture
    Figure 5. Global Active Pharmaceutical Ingredients (API) Market Share by Application in 2021 & 2028
    Figure 6. CNS
    Figure 7. Cardiovascular
    Figure 8. Genitourinary/Hormonal Drugs
    Figure 9. Respiratory
    Figure 10. Rheumatology
    Figure 11. Diabetes
    Figure 12. Oncology
    Figure 13. Others
    Figure 14. Active Pharmaceutical Ingredients (API) Report Years Considered
    Figure 15. Global Active Pharmaceutical Ingredients (API) Capacity, Production and Utilization (2017-2028) & (Tons)
    Figure 16. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2017-2022)
    Figure 18. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2023-2028)
    Figure 19. Active Pharmaceutical Ingredients (API) Production Growth Rate in North America (2017-2028) & (Tons)
    Figure 20. Active Pharmaceutical Ingredients (API) Production Growth Rate in Europe (2017-2028) & (Tons)
    Figure 21. Active Pharmaceutical Ingredients (API) Production Growth Rate in China (2017-2028) & (Tons)
    Figure 22. Active Pharmaceutical Ingredients (API) Production Growth Rate in Japan (2017-2028) & (Tons)
    Figure 23. Active Pharmaceutical Ingredients (API) Production Growth Rate in India (2017-2028) & (Tons)
    Figure 24. Global Active Pharmaceutical Ingredients (API) Sales 2017-2028 (Tons)
    Figure 25. Global Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 26. Global Active Pharmaceutical Ingredients (API) Revenue 2017-2028 (US$ Million)
    Figure 27. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 28. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2022)
    Figure 29. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2023-2028)
    Figure 30. North America Active Pharmaceutical Ingredients (API) Sales YoY (2017-2028) & (Tons)
    Figure 31. North America Active Pharmaceutical Ingredients (API) Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Europe Active Pharmaceutical Ingredients (API) Sales YoY (2017-2028) & (Tons)
    Figure 33. Europe Active Pharmaceutical Ingredients (API) Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales YoY (2017-2028) & (Tons)
    Figure 35. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue YoY (2017-2028) & (US$ Million)
    Figure 36. Latin America Active Pharmaceutical Ingredients (API) Sales YoY (2017-2028) & (Tons)
    Figure 37. Latin America Active Pharmaceutical Ingredients (API) Revenue YoY (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales YoY (2017-2028) & (Tons)
    Figure 39. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue YoY (2017-2028) & (US$ Million)
    Figure 40. The Active Pharmaceutical Ingredients (API) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 41. The Top 5 and 10 Largest Manufacturers of Active Pharmaceutical Ingredients (API) in the World: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2021
    Figure 42. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 43. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    Figure 44. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    Figure 45. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    Figure 46. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    Figure 47. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    Figure 48. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    Figure 49. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    Figure 50. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    Figure 51. North America Active Pharmaceutical Ingredients (API) Sales Share by Country (2017-2028)
    Figure 52. North America Active Pharmaceutical Ingredients (API) Revenue Share by Country (2017-2028)
    Figure 53. U.S. Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 54. Canada Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 55. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    Figure 56. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    Figure 57. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    Figure 58. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    Figure 59. Europe Active Pharmaceutical Ingredients (API) Sales Share by Country (2017-2028)
    Figure 60. Europe Active Pharmaceutical Ingredients (API) Revenue Share by Country (2017-2028)
    Figure 61. Germany Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 62. France Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 63. U.K. Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 64. Italy Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 65. Russia Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 66. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    Figure 67. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    Figure 68. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    Figure 69. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    Figure 70. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Share by Region (2017-2028)
    Figure 71. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Share by Region (2017-2028)
    Figure 72. China Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 73. Japan Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 74. South Korea Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 75. India Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 76. Australia Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 77. Taiwan Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 78. Indonesia Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 79. Thailand Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 80. Malaysia Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 81. Philippines Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 82. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)
    Figure 83. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)
    Figure 84. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)
    Figure 85. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)
    Figure 86. Latin America Active Pharmaceutical Ingredients (API) Sales Share by Country (2017-2028)
    Figure 87. Latin America Active Pharmaceutical Ingredients (API) Revenue Share by Country (2017-2028)
    Figure 88. Mexico Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (US$ Million)
    Figure 89
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Frequently Asked Questions
Active Pharmaceutical Ingredients (API) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Active Pharmaceutical Ingredients (API) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Active Pharmaceutical Ingredients (API) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

SIM Cards

SIM Cards market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More

Foam Roller

Foam Roller market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Sprocket

Sprocket market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Herbal Medicine

Herbal Medicine market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More